CIK 0001444192 · Non-accelerated filer<br>Smaller reporting company
Grace Therapeutics, Inc.
Sign in to watch- Ticker
- GRCE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 609-322-1602
- Business address
- 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
- Former names
- Acasti Pharma Inc.
- Open-market buys, last 90 days
- $814,975
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$814,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | Kohli Prashant Chief Executive Officer | Purchase | +100,000 | $2.14 | $214K | 121,357 |
| 2026-08-28 | Kohli Prashant Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +267,160 | 267,160 | ||
| 2025-04-14 | Kohli Prashant Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +225,400 | 225,400 | ||
| 2024-05-06 | Kohli Prashant Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +128,770 | 128,770 | ||
| 2023-12-19 | Kohli Prashant Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +41,668 | 41,668 | ||
| 2023-07-14 | Kohli Prashant Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +208,334 | 208,334 |
Page 1 of 1 · 6 trades